Samples for the validation will be collected at the Catholic University of Korea and will represent people across all stages of Alzheimer's disease.

The deal for shares and cash is expected to close in the first half of 2025, and Sonic expects that it will be immediately accretive to earnings per share.

The system includes the Cobas I 601 analyzer and the first Ionify reagent pack of four assays for steroid hormones.

NEW YORK – Multiple coverage and reimbursement decisions from the US Centers for Medicare and Medicaid Services had a significant impact on the in vitro diagnostics industry this year, and as a new ...

Tracer has developed a proprietary platform for tumor-informed circulating-tumor DNA detection using digital PCR.

Last week, readers were most interested in a story about Gates Foundation Awards to Detact Diagnostics to further develop a POC system and assays to detect infectious diseases.

Labcorp will acquire portions of the lab's clinical and women's health testing businesses, while MAWD will continue to provide anatomic and other pathology services.

The Diagnostics Development Services program is, so far, being used to help point-of-care testing firm Fluxergy bring to market a test for sexually transmitted infections.

The firm also has plans for tests beyond sepsis, including for cardiac events and other conditions that are commonly treated in acute care settings.

Mansinh Chaudhari purchased Medicare beneficiary information and sold it to healthcare providers who then submitted unnecessary COVID-19 tests for those beneficiaries.

NEW YORK – Bio-Techne announced on Thursday that it has inked a distribution deal with MedSanTek to distribute Bio-Techne products in Turkey.

The deal involves the implementation in Limbach Group labs of Noul's automated MiLab instrument that uses microscopy and AI-developed algorithms to analyze samples.